← Back
$COLL All transactions

COLLEGIUM PHARMACEUTICAL, INC

▼ SELL

$ Value

$401K

Shares

11,659

Price

$34

Filed

Aug 12

Insider

Name

Freund John Gordon

Title

CIK

0001296771

Roles

Director

Transaction Details

Transaction Date

2025-08-08

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

23,129

Footnotes

The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.27 to $34.535, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The shares are held by the John Freund Family Partnership IV, L.P. ("Freund LP"). The Reporting Person is the trustee and beneficiary of the The John G. Freund Revocable Trust u/a/d 6/26/01 which serves as the general partner of Freund LP. The Reporting Person disclaims beneficial ownership of the shares held by Freund LP except to the extent of his proportionate pecuniary interest therein. | The shares are held by Skyline Venture Management V, LLC. John G. Freund and Yasunori Kaneko are managers of Skyline Venture Management V, LLC. These individuals share voting and investment power over the shares held by Skyline Venture Management V, LLC. The Reporting Person disclaims beneficial ownership of all the shares held by Skyline Venture Management V, LLC except to the extent of his proportionate pecuniary interest therein.

Filing Info

Accession No.

0001062993-25-014202

Form Type

4

Issuer CIK

0001267565

Freund John Gordon's History

Date Ticker Type Value
2025-08-08 SIBN $194K
2025-08-08 COLL $401K
2025-06-09 COLL M $202K
2025-06-09 COLL $202K
2025-06-09 COLL M $0
2025-06-05 SIBN A $0
2025-05-15 COLL A $0

Other Insiders at COLL (90d)

Insider Bought Sold Last
Karnani Vikram
President and CEO
2026-02-10
Dreyer Scott
EVP & Chief Commercial Officer
2026-02-10
Smith Thomas B
EVP and Chief Medical Officer
2026-02-10
Tupper Colleen
EVP & Chief Financial Officer
2026-02-10
Dieter David
EVP & General Counsel
2026-03-17